Publications by authors named "Janice Shaw"

Claim this Profile
I
Identification of biomarkers for glycaemic deterioration in type 2 diabetes.
Roderick C Slieker, Louise A Donnelly, Elina Akalestou, Livia Lopez-Noriega, Rana Melhem, Janice L Shaw

Nat Commun· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-islet glucagon confers β-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon.
Over Cabrera, James Ficorilli, Janice Shaw, Felipe Echeverri, Frank Schwede

J Biol Chem· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Episodic β-cell death and dedifferentiation during diet-induced obesity and dysglycemia in male mice.
Sarah A Tersey, Esther M Levasseur, Farooq Syed, Thomas B Farb, Kara S Orr, Janice L Shaw

FASEB J· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-Hydroxytryptamine 1A (5HT1A) receptors mediate increases in plasma glucose independent of corticosterone.
Donald R Gehlert, Janice Shaw

Eur J Pharmacol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LLY-2707, a novel nonsteroidal glucocorticoid antagonist that reduces atypical antipsychotic-associated weight gain in rats.
Dana K Sindelar, Mathew W Carson, Michelle Morin, Janice Shaw, Robert J Barr

J Pharmacol Exp Ther· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-HT1A receptor antagonists reduce food intake and body weight by reducing total meals with no conditioned taste aversion.
M Joelle Dill, Janice Shaw, Jeff Cramer, Dana K Sindelar

Pharmacol Biochem Behav· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of alcohol self-administration and reinstatement of alcohol seeking by melanin-concentrating hormone receptor 1 (MCH1-R) antagonism in Wistar rats.
Andrea Cippitelli, Camilla Karlsson, Janice L Shaw, Annika Thorsell, Donald R Gehlert

Psychopharmacology (Berl)· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression.
Donald R Gehlert, Kurt Rasmussen, Janice Shaw, Xia Li, Paul Ardayfio

J Pharmacol Exp Ther· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoaminergic compensation in the neuropeptide Y deficient mouse brain.
Donald R Gehlert, Linda K Thompson, Susan K Hemrick-Luecke, Janice Shaw

Neuropeptides· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function.
Donald R Gehlert, Janice L Shaw

Peptides· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 5.
Kumiko Takeuchi, Todd J Kohn, Nicholas A Honigschmidt, Vincent P Rocco, Patrick G Spinazze, Janice Shaw

Bioorg Med Chem Lett· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of nociceptin and Ro64-6198 activated [35S]-GTPgammaS binding in the rat brain.
Donald R Gehlert, Susan L Gackenheimer, Janice L Shaw

Neuropeptides· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor.
Donald R Gehlert, Anantha Shekhar, S Michelle Morin, Phillip A Hipskind, Charity Zink, Janice Shaw

Eur J Pharmacol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice.
Daniel G Smith, Eleni T Tzavara, Janice Shaw, Susan Luecke, Mark Wade

J Neurosci· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4.
Vincent P Rocco, Patrick G Spinazze, Todd J Kohn, Nicholas A Honigschmidt, David L Nelson, Janice Shaw

Bioorg Med Chem Lett· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 3.
Kumiko Takeuchi, Todd J Kohn, Nicholas A Honigschmidt, Vincent P Rocco, Patrick G Spinazze, Janice Shaw

Bioorg Med Chem Lett· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional autoradiography of neuropeptide Y Y1 and Y2 receptor subtypes in rat brain using agonist stimulated [35S]GTPgammaS binding.
Janice L Shaw, Susan L Gackenheimer, Donald R Gehlert

J Chem Neuroanat· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances Toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT(1A) receptor antagonism/SSRI activities. Part 2.
Kumiko Takeuchi, Todd J Kohn, Nicholas A Honigschmidt, Vincent P Rocco, Patrick G Spinazze, Janice Shaw

Bioorg Med Chem Lett· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1.
Kumiko Takeuchi, Todd J Kohn, Nicholas A Honigschmidt, Vincent P Rocco, Patrick G Spinazze, Janice Shaw

Bioorg Med Chem Lett· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex.
Frank P Bymaster, Wei Zhang, Petra A Carter, Janice Shaw, Eyassu Chernet

Psychopharmacology (Berl)· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis